Literature DB >> 15240594

Weight of normal parathyroid glands in patients with parathyroid adenomas.

Kathy Yao1, Frederick R Singer, Sanford I Roth, Aaron Sassoon, Cynthia Ye, Armando E Giuliano.   

Abstract

Although the size and weight of a parathyroid gland are frequently the only intraoperative determinants of abnormality, these parameters have not been examined in living patients with primary hyperparathyroidism (PHP). The records of 240 patients who underwent parathyroidectomy according to standard surgical practice by a single surgeon were reviewed to identify those who were euparathyroid after in toto removal of a histologically confirmed normal gland and a histologically confirmed adenoma. The 25 (86%) females and 4 (14%) males who met the study criteria had a mean age of 60 yr (range, 33-82 yr). The mean PTH level was 130.1 pg/ml (range, 58-278) before parathyroidectomy and 32.4 pg/ml (range, 1-68) after parathyroidectomy. The mean calcium level was 11.1 mg/dl (range, 10-14) before and 8.7 mg/dl (range, 8-10) after parathyroidectomy. Thirty-four intact normal glands were removed and available for analysis. Their mean weight was 62.4 +/- 31.6 mg (range, 18-161 mg), and 15 (44%) weighed 60 mg or more. The mean weight of the adenomas was 553.7 +/- 520.5 mg (range, 66-2536). Adenomas were clearly distinguished from normal glands by cellularity, stromal fat, and intracellular fat in chief cells. The weight of normal parathyroid glands removed at surgery in patients with PHP may be greater than that reported in autopsy studies. Therefore, certain histological features are a better measure than weight in determining whether a gland is normal, and intraoperative identification of slightly enlarged glands should not lead to immediate subtotal parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240594     DOI: 10.1210/jc.2003-031184

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  New Concepts About Familial Isolated Hyperparathyroidism.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2019-03-08       Impact factor: 5.958

2.  Molecular diagnosis in head and neck: what a surgical pathologist must know.

Authors:  Jennifer L Hunt
Journal:  Head Neck Pathol       Date:  2008-02-26

Review 3.  Pediatric hyperparathyroidism: review and imaging update.

Authors:  Hedieh Khalatbari; Safia H E Cheeney; Scott C Manning; Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2021-04-27

4.  Ectopic Pleural Parathyroid Adenoma Causing Recurrent Primary Hyperparathyroidism.

Authors:  Jasleen Kaur; Tyler Drake
Journal:  Cureus       Date:  2022-05-18

5.  Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease.

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Emanuela Traini; Enrico Di Stasio; Cinzia Carrozza; Carmela De Crea; Cecilia Zuppi; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2008-07-24       Impact factor: 3.445

6.  A Simple Formula to Estimate Parathyroid Weight on 4D-CT, Predict Pathologic Weight, and Diagnose Parathyroid Adenoma in Patients with Primary Hyperparathyroidism.

Authors:  R Yeh; Y-K D Tay; L Dercle; L Bandeira; M R Parekh; J P Bilezikian
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-13       Impact factor: 3.825

7.  Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary?

Authors:  Mitchell R Lunn; Jair Muñoz Mendoza; Lezlee J Pasche; Jeffrey A Norton; Alexander L Ayco; Glenn M Chertow
Journal:  NDT Plus       Date:  2010-05-05

8.  Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism.

Authors:  Bin Guan; James M Welch; Meghana Vemulapalli; Yulong Li; Hua Ling; Electron Kebebew; William F Simonds; Stephen J Marx; Sunita K Agarwal
Journal:  J Endocr Soc       Date:  2017-03-23

9.  Is dual-phase SPECT/CT with 99mTc-sestamibi better than single-phase SPECT/CT for lesion localization in patients with hyperparathyroidism?

Authors:  Suk Hyun Lee; Eonwoo Shin; Sejin Ha; Jungsu S Oh; Dong Eun Song; Jin-Sook Ryu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

10.  Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas.

Authors:  Jessica Costa-Guda; Takehiko Tokura; Sanford I Roth; Andrew Arnold
Journal:  BMC Endocr Disord       Date:  2007-10-04       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.